Author:
Gandhi V.,Estey E.,Keating M. J.,Plunkett W.
Publisher
Springer Berlin Heidelberg
Reference12 articles.
1. Damon LE, Cadman EC (1988) The metabolic basis for combination chemotherapy. Pharmacol Ther 38: 73–127
2. Gandhi V, Plunkett W (1988) Modulation of arabionosylnucleoside metabolism by arabinosylnucleotides in human leukemia cells. Cancer Res 48: 329–334
3. Gandhi V, Nowak, B, Keating MJ, Plunkett W (1989) Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood 74: 2070–2075
4. Gandhi V, Plunkett W (1990) Modulatory activity of 2’, 2’-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res 50: 3675–3680
5. Preisler HD, Rustum Y, Priore R (1985) Relationship between leukemic cell metabolism of cytosine arabinoside and the outcome of chemotherapy for acute myelocytic leukemia. Eur J Cancer Clin Oncol 20: 1061–1066